Cepheid Locks Up Two More Patents | GenomeWeb

NEW YORK, April 11 - The US government has awarded Cepheid a patent for its I-CORE technology, which allows for "simultaneous, real-time optical excitation and detection of two or more nucleic acids," and one for a technology that allows for the "automated preparation of biological samples using chip-based microfluidics technology."

To date, Cepheid has 36 US patents either issued or pending, plus corresponding foreign patent applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.